323 related articles for article (PubMed ID: 28440483)
1. Human osteopontin: Potential clinical applications in cancer (Review).
Hao C; Cui Y; Owen S; Li W; Cheng S; Jiang WG
Int J Mol Med; 2017 Jun; 39(6):1327-1337. PubMed ID: 28440483
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin splice variants and polymorphisms in cancer progression and prognosis.
Briones-Orta MA; Avendaño-Vázquez SE; Aparicio-Bautista DI; Coombes JD; Weber GF; Syn WK
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):93-108.A. PubMed ID: 28254527
[TBL] [Abstract][Full Text] [Related]
3. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines.
Silva GR; Mattos DS; Bastos ACF; Viana BPPB; Brum MCM; Ferreira LB; Gimba ERP
Mol Biol Rep; 2020 Oct; 47(10):8339-8345. PubMed ID: 33006711
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.
Yan W; Qian C; Zhao P; Zhang J; Shi L; Qian J; Liu N; Fu Z; Kang C; Pu P; You Y
Neuro Oncol; 2010 Aug; 12(8):765-75. PubMed ID: 20511184
[TBL] [Abstract][Full Text] [Related]
6. Full-length osteopontin and its splice variants as modulators of chemoresistance and radioresistance (Review).
Gimba ERP; Brum MCM; Nestal De Moraes G
Int J Oncol; 2019 Feb; 54(2):420-430. PubMed ID: 30535434
[TBL] [Abstract][Full Text] [Related]
7. Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer.
Rohde F; Rimkus C; Friederichs J; Rosenberg R; Marthen C; Doll D; Holzmann B; Siewert JR; Janssen KP
Int J Cancer; 2007 Oct; 121(8):1717-23. PubMed ID: 17565744
[TBL] [Abstract][Full Text] [Related]
8. Role of osteopontin in cellular signaling and metastatic phenotype.
El-Tanani MK
Front Biosci; 2008 May; 13():4276-84. PubMed ID: 18508510
[TBL] [Abstract][Full Text] [Related]
9. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.
Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
J Cell Mol Med; 2010 Aug; 14(8):2037-44. PubMed ID: 20597997
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma.
Sullivan J; Blair L; Alnajar A; Aziz T; Chipitsyna G; Gong Q; Yeo CJ; Arafat HA
Histol Histopathol; 2011 Jul; 26(7):893-904. PubMed ID: 21630219
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin as a therapeutic target for cancer.
Bandopadhyay M; Bulbule A; Butti R; Chakraborty G; Ghorpade P; Ghosh P; Gorain M; Kale S; Kumar D; Kumar S; Totakura KV; Roy G; Sharma P; Shetti D; Soundararajan G; Thorat D; Tomar D; Nalukurthi R; Raja R; Mishra R; Yadav AS; Kundu GC
Expert Opin Ther Targets; 2014 Aug; 18(8):883-95. PubMed ID: 24899149
[TBL] [Abstract][Full Text] [Related]
12. The role of osteopontin expression in melanoma progression.
Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
[TBL] [Abstract][Full Text] [Related]
13. Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways.
Gimba ER; Tilli TM
Cancer Lett; 2013 Apr; 331(1):11-7. PubMed ID: 23246372
[TBL] [Abstract][Full Text] [Related]
14. The role of osteopontin in the progression of solid organ tumour.
Zhao H; Chen Q; Alam A; Cui J; Suen KC; Soo AP; Eguchi S; Gu J; Ma D
Cell Death Dis; 2018 Mar; 9(3):356. PubMed ID: 29500465
[TBL] [Abstract][Full Text] [Related]
15. [Expression of osteopontin splice variant and its clinical significance in gastric cancer].
Sun X; Wang L; Hou W; Li Y; Liu L; Zuo W; Yu J
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):427-30. PubMed ID: 26463145
[TBL] [Abstract][Full Text] [Related]
16. Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Kiss T; Jámbor K; Koroknai V; Szász I; Bárdos H; Mokánszki A; Ádány R; Balázs M
Pathol Oncol Res; 2021; 27():581395. PubMed ID: 34257527
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma.
Siddiqui AA; Jones E; Andrade D; Shah A; Kowalski TE; Loren DE; Chipitsyna G; Arafat HA
J Gastroenterol Hepatol; 2014 Jun; 29(6):1321-7. PubMed ID: 24548099
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
Wohlleben G; Hauff K; Gasser M; Waaga-Gasser AM; Grimmig T; Flentje M; Polat B
Oncol Rep; 2018 Jan; 39(1):442-448. PubMed ID: 29115557
[TBL] [Abstract][Full Text] [Related]
19. The osteopontin-c splice junction is important for anchorage-independent growth.
Shen H; Weber GF
Mol Carcinog; 2014 Jun; 53(6):480-7. PubMed ID: 23359517
[TBL] [Abstract][Full Text] [Related]
20. Assessing SPP1/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential.
Chou CF; Huang CC; Bin Dabil N; Chang PL
Cancer Invest; 2021; 39(6-7):559-570. PubMed ID: 34043476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
